Assessment of Maternal and Perinatal Morbidity and Mortality in Vaginal and Cesarean Delivery

January 13, 2019 updated by: Alzahraa Ismail Ragheb Goda

Assessment of Maternal and Perinatal Morbidity and Mortality in Vaginal and Cesarean Delivery Among a Sample of Women Delivering at Ain Shams University Maternity Hospital

This study will be done at Ain Shams university maternity hospital to identify the significant risk of maternal intensive care unit admission, need for advanced surgery, postpartum hemorrhage, need for blood transfusion, febrile morbidity, neonatal intensive care unit admission (NICU), need for neonatal intubation and low APGAR scoring in both vaginal and cesarean section .and this will lead us to know if cesarean section rates in our unit is a safe alternative to vaginal delivery and which of both maneuvers will introduce fewer hazards to mother and fetus.

Study Overview

Detailed Description

  • Type of Study: a cross-sectional study
  • Study Setting: Ain Shams maternity hospital
  • Study Period: 6 months
  • Study Population: in this prospective study, all women who deliver vaginally and by cesarean section at Ain Shams maternity hospital will be included.
  • Sampling Method: All of the pregnant women who will deliver vaginally and all of pregnant women who will deliver by cesarean sections in the labor delivery room at Ain Shams University Maternity Hospital on a fixed day and by a fixed team over a period of 6 months
  • Sample Size: all pregnant women who will deliver at Ain Shams maternity hospital.
  • Inclusion criteria :

    • All of the patients who will deliver vaginally
    • All of the patients who will deliver by cesarean sections.
  • Exclusion criteria: no exclusion criteria, all women who will attend for delivery will be included.
  • Ethical Considerations: the study objectives will be briefly and clearly described to all participants and an oral consent will be obtained from all patients.
  • Study Procedures :

In all selected cases the following will be recorded:

Parameters of maternal morbidity:

  1. ICU admission due to the complication of delivery.
  2. Need for advanced surgery (int. iliac ligation -hysterectomy -or due to the injury of pelvic organs).
  3. Febrile morbidity temp >38C on two or more occasion within 48h of delivery.
  4. Postpartum hemorrhage (blood loss 500cc in VD and 1liter in C\S).
  5. Wound infection.
  6. Late complications e.g. (D.V.T-puerperal sepsis and hematoma).
  7. Need for blood transfusion post labor
  8. Maternal mortality.

Parameters of fetal morbidity:

  1. Intracranial hemorrhage as compilations of delivery.
  2. Neonatal ICU admission as compilations of delivery
  3. Fracture (Femur, ribs, and humorous)
  4. Meconium aspiration.
  5. Erb's palsy.
  6. APGARscore1-5.
  7. Need for intubation during resuscitation.

    • Statistical analysis The patient will be subdivided into 4 groups, normal VD, instrumental VD, emergency C\S, and elective C\S The data has been collected in analytical sheet tabulated and statistical analysis using the following tests

1- T-test. 2- Chi-square test. 3- Fisher exact test

Statistical package :

data analysis will be performed by SPSS 16.0 using descriptive statistics tools, including mean, standard deviation and figures.A t-test will be used to compare mean values of the two groups .P-values, smaller than 0.05, were considered statistically significant.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 48 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

all women who delivered vaginally and by cesarean section at Ain Shams maternity hospital will be included.

Description

Inclusion Criteria:

  • All of the patients who will deliver vaginally
  • All of the patients who will deliver by cesarean sections.

Exclusion Criteria:

  • no exclusion criteria, all women who will attend for delivery will be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
normal vaginal delivery
assisted vaginal delivery
elective cesarean delivery
women delivered by cesarean section
emergency cesarean delivery
women delivered by cesarean section

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
labor and delivery outcome
Time Frame: 24 hours
document maternal and perinatal morbidity
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tamer F Borg, professor, Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2018

Primary Completion (Anticipated)

March 1, 2019

Study Completion (Anticipated)

April 1, 2019

Study Registration Dates

First Submitted

September 10, 2018

First Submitted That Met QC Criteria

September 10, 2018

First Posted (Actual)

September 11, 2018

Study Record Updates

Last Update Posted (Actual)

January 15, 2019

Last Update Submitted That Met QC Criteria

January 13, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • zahra2018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delivery ,Complications,Maternal

Clinical Trials on cesarean delivery

3
Subscribe